Structure Database (LMSD)

LM_ID Common Name Systematic Name Main class Sub class Mass Formula
LMSP0601EB07 KDN-lactotetraosylceramide(d18:1/24:1(15Z)) KDNalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1586.93 C77H138N2O31
LMSP0601EB06 KDN-lactotetraosylceramide(d18:1/26:0) KDNalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1616.98 C79H144N2O31
LMSP0601EB08 KDN-lactotetraosylceramide(d18:1/26:1(17Z)) KDNalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1614.96 C79H142N2O31
LMSP0601DE01 KDNGD1a(d18:1/16:0) KDNalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1726.89 C78H138N2O39
LMSP0601DE02 KDNGD1a(d18:1/18:0) KDNalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1754.92 C80H142N2O39
LMSP0601DE03 KDNGD1a(d18:1/20:0) KDNalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1782.95 C82H146N2O39
LMSP0601DE04 KDNGD1a(d18:1/22:0) KDNalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1810.98 C84H150N2O39
LMSP0601DE05 KDNGD1a(d18:1/24:0) KDNalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1839.01 C86H154N2O39
LMSP0601DE07 KDNGD1a(d18:1/24:1(15Z)) KDNalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1837 C86H152N2O39
LMSP0601DE06 KDNGD1a(d18:1/26:0) KDNalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1867.04 C88H158N2O39
LMSP0601DE08 KDNGD1a(d18:1/26:1(17Z)) KDNalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1865.03 C88H156N2O39
LMSP0601CB01 Neu5Ac)GD1a(d18:1/16:0) KDNalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1767.91 C80H141N3O39
LMSP0601CB02 Neu5Ac)GD1a(d18:1/18:0) KDNalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1795.95 C82H145N3O39
LMSP0601CB03 Neu5Ac)GD1a(d18:1/20:0) KDNalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1823.98 C84H149N3O39
LMSP0601CB04 Neu5Ac)GD1a(d18:1/22:0) KDNalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1852.01 C86H153N3O39
LMSP0601CB05 Neu5Ac)GD1a(d18:1/24:0) KDNalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1880.04 C88H157N3O39
LMSP0601CB07 Neu5Ac)GD1a(d18:1/24:1(15Z)) KDNalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1878.02 C88H155N3O39
LMSP0601CB06 Neu5Ac)GD1a(d18:1/26:0) KDNalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1908.07 C90H161N3O39
LMSP0601CB08 Neu5Ac)GD1a(d18:1/26:1(17Z)) KDNalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1906.06 C90H159N3O39
LMSP0601AB01 SSEA-4 antigen(d18:1/16:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1679.9 C77H137N3O36
LMSP0601AB02 SSEA-4 antigen(d18:1/18:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1707.93 C79H141N3O36
LMSP0601AB03 SSEA-4 antigen(d18:1/20:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1735.96 C81H145N3O36
LMSP0601AB04 SSEA-4 antigen(d18:1/22:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1763.99 C83H149N3O36
LMSP0601AB05 SSEA-4 antigen(d18:1/24:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1792.02 C85H153N3O36
LMSP0601AB07 SSEA-4 antigen(d18:1/24:1(15Z)) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1790.01 C85H151N3O36
LMSP0601AB06 SSEA-4 antigen(d18:1/26:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1820.05 C87H157N3O36
LMSP0601AB08 SSEA-4 antigen(d18:1/26:1(17Z)) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1818.04 C87H155N3O36
LMSP0601AI01 SSEA-4 positional isomer(d18:1/16:0) NeuAcalpha2-6Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1679.9 C77H137N3O36
LMSP0601AI02 SSEA-4 positional isomer(d18:1/18:0) NeuAcalpha2-6Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1707.93 C79H141N3O36
LMSP0601AI03 SSEA-4 positional isomer(d18:1/20:0) NeuAcalpha2-6Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1735.96 C81H145N3O36
LMSP0601AI04 SSEA-4 positional isomer(d18:1/22:0) NeuAcalpha2-6Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1763.99 C83H149N3O36
LMSP0601AI05 SSEA-4 positional isomer(d18:1/24:0) NeuAcalpha2-6Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1792.02 C85H153N3O36
LMSP0601AI07 SSEA-4 positional isomer(d18:1/24:1(15Z)) NeuAcalpha2-6Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1790.01 C85H151N3O36
LMSP0601AI06 SSEA-4 positional isomer(d18:1/26:0) NeuAcalpha2-6Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1820.05 C87H157N3O36
LMSP0601AI08 SSEA-4 positional isomer(d18:1/26:1(17Z)) NeuAcalpha2-6Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1818.04 C87H155N3O36
LMSP0601CH01 Sialyl-Lea(d18:1/16:0) NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1663.9 C77H137N3O35
LMSP0601CH02 Sialyl-Lea(d18:1/18:0) NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1691.93 C79H141N3O35
LMSP0601CH03 Sialyl-Lea(d18:1/20:0) NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1719.97 C81H145N3O35
LMSP0601CH04 Sialyl-Lea(d18:1/22:0) NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1748 C83H149N3O35
LMSP0601CH05 Sialyl-Lea(d18:1/24:0) NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1776.03 C85H153N3O35
LMSP0601CH07 Sialyl-Lea(d18:1/24:1(15Z)) NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1774.01 C85H151N3O35
LMSP0601CH06 Sialyl-Lea(d18:1/26:0) NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1804.06 C87H157N3O35
LMSP0601CH08 Sialyl-Lea(d18:1/26:1(17Z)) NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1802.04 C87H155N3O35
LMSP0601FJ01 VIM-II(d18:1/16:0) NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2029.04 C91H160N4O45
LMSP0601FJ02 VIM-II(d18:1/18:0) NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2057.07 C93H164N4O45
LMSP0601FJ03 VIM-II(d18:1/20:0) NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2085.1 C95H168N4O45
LMSP0601FJ04 VIM-II(d18:1/22:0) NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2113.13 C97H172N4O45
LMSP0601FJ05 VIM-II(d18:1/24:0) NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2141.16 C99H176N4O45
LMSP0601FJ07 VIM-II(d18:1/24:1(15Z)) NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2139.15 C99H174N4O45
LMSP0601FJ06 VIM-II(d18:1/26:0) NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2169.19 C101H180N4O45